According to Futurewise analysis, the Global Repairing Chordae Tendineae (CT) market is estimated to grow 1.68x between 2024 and 2032, creating an absolute opportunity of more than USD 234 million. The market is experiencing growth due to a rising prevalence of mitral valve disorders and an increasing adoption of minimally invasive cardiac surgical techniques worldwide. This expansion is driven by technological advancements in artificial chordae materials and surgical instruments, as well as a growing awareness of the benefits of early intervention for patients with chordae tendineae rupture. Moreover, the aging global population and improvements in healthcare infrastructure in emerging markets are expected to significantly increase the demand for chordae tendineae (CT) repair procedures during the forecast period.

The artificial chordae market was valued at USD 500 million in 2024 and is projected to experience significant growth, reaching an estimated USD 1.2 billion by 2035. This growth indicates a compound annual growth rate (CAGR) of approximately 9.1%. Major companies operating in this sector include Abbott, Edwards Lifesciences, CryoLife, and Medtronic, highlighting a competitive landscape that aims to advance technologies in heart valve repair and replacement. The market for repairing Chordae Tendineae (CT) is expected to grow due to the increasing prevalence of mitral valve diseases and advancements in minimally invasive cardiac surgeries. Additionally, the rising elderly population, which is more susceptible to degenerative heart conditions, is further driving the demand for chordae tendineae repair procedures. Researchers are developing dynamic valve simulations that are customized for individual patients by using 3D-printed models to evaluate repair strategies. This approach is particularly important for repairing pediatric atrioventricular valves. In a case series focused on the surgical repair of mitral valve prolapse caused by elongated papillary muscles, pre-measured artificial chordae were utilized, leading to a precise refinement of traditional surgical techniques.

FutureWise Market Research has released a report providing an in-depth analysis of Repairing Chordae Tendineae (CT) Market trends that will impact overall market growth.

Request a Free Sample @

https://www.futurewiseresearch.com/contact.aspx?rpt=15644&type=requestsample

By Product Type

• Biological Grafts
• Artificial Chordae Tendineae
• Forceps
• Heart Lung Machine
• Others

By Patient Demographic

• Pediatric
• Adult
• Geriatric

By Technology

• Invasive Procedures
• Minimally-Invasive Procedures

By End-User

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers (ASCs)

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape in Repairing Chordae Tendineae (CT) Market:

• Gore Medical
• NeoChord, Inc.
• Medtronic
• Abbott Laboratories
• Edwards Lifesciences
• Aesculap AG
• Fehling Surgical Instruments, Inc.
• LivaNova (formerly Sorin Group)
• Lepu Medical Technology Co ltd.
• Terumo Corporation

Recent developments by key players in the Repairing Chordae Tendineae (CT) Market:

NeoChord, Inc.

• Received FDA Investigational Device Exemption (IDE) to initiate a pivotal clinical trial of their artificial chordae delivery system across 20 mitral repair centers in the U.S.
• The NeoChord DS1000 is a transapical system designed for beating-heart procedures, and it has been gaining attention in clinical forums and registries, targeting broader adoption in Europe and the U.S.

Abbott Laboratories

• In June 2025, Abbott Laboratories partnered with CryoLife to collaboratively develop technologies for artificial chordae replacement.
• Edwards Lifesciences (February 2025) has acquired ChordArt Medical, enhancing its artificial chordae platform.

Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=15644&license=multi

**Objectives of this Study: **

1. To provide a comprehensive analysis of the Repairing Chordae Tendineae (CT) Market By Product Type, By Patient Demographic, By Technology, By End-User and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

                                                                                                                
Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are free of charge with the purchase of any license of the report.
• You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com